R. M. Steinman, The Dendritic Cell System and its Role in Immunogenicity, Annual Review of Immunology, vol.9, issue.1, pp.271-296, 1991.
DOI : 10.1146/annurev.iy.09.040191.001415

A. Y. Huang, P. Golumbek, M. Ahmadzadeh, E. Jaffee, D. Pardoll et al., Bone Marrow-Derived Cells Present MHC Class I-Restricted Tumour Antigens in Priming of Antitumour Immune Responses, Ciba Found. Symp, vol.53, issue.18, pp.229-240, 1994.
DOI : 10.1002/9780470514672.ch15

T. D. Armstrong, B. A. Pulaski, and S. Ostrand-rosenberg, Tumor antigen presentation: changing the rules, Cancer Immunology, Immunotherapy, vol.46, issue.2, pp.70-74, 1998.
DOI : 10.1007/s002620050463

M. Colonna, G. Trimchieri, and Y. J. Liu, Plasmacytoid dendritic cells in immunity, Nature Immunology, vol.165, issue.12, pp.1219-1226, 2004.
DOI : 10.1038/32588

D. W. O-'neill, A. Sylvia, and N. Bhardwaj, Manipulating dendritic cell biology for the active immunotherapy of cancer, Blood, vol.104, issue.8, pp.2235-2246, 2004.
DOI : 10.1182/blood-2003-12-4392

F. Facchetti, C. De-wolf-peeters, J. J. Van-den-oord, R. De-vos, and V. J. Desmet, Plasmacytoid monocytes (so-called plasmacytoid T-cells) in Kikuchi's lymphadenitis. An immunohistologic study, Am, J. Clin. Pathol, pp.92-133, 1989.

A. Dzionek, A. Fuchs, P. Schmidt, S. Cremer, M. Zysk et al., BDCA-2, BDCA-3, and BDCA-4: Three Markers for Distinct Subsets of Dendritic Cells in Human Peripheral Blood, The Journal of Immunology, vol.165, issue.11, pp.165-6037, 2000.
DOI : 10.4049/jimmunol.165.11.6037

G. Grouard, M. C. Rissoan, L. Filgueira, I. Durand, J. Banchereau et al., The Enigmatic Plasmacytoid T Cells Develop into Dendritic Cells with Interleukin (IL)-3 and CD40-Ligand, The Journal of Experimental Medicine, vol.153, issue.6, pp.185-1101, 1997.
DOI : 10.1084/jem.185.2.341

N. J. Poindexter, A. Sahin, K. K. Hunt, and E. A. Grimm, Analysis of dendritic cells in tumor-free and tumor-containing sentinel lymph nodes from patients with breast cancer, Breast Cancer Research, vol.58, issue.Suppl, pp.408-415, 2004.
DOI : 10.1245/aso.2002.9.1.82

R. Kim, M. Emi, and K. Tanabe, Cancer immunoediting from immune surveillance to immune escape, Immunology, vol.1, issue.1, pp.1-14, 2007.
DOI : 10.1046/j.1440-1711.2002.01115.x
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2265921

G. A. Rabinovich, D. Gabrilovich, and E. M. Sotomayor, Immunosuppressive Strategies that are Mediated by Tumor Cells, Annual Review of Immunology, vol.25, issue.1, pp.267-296, 2007.
DOI : 10.1146/annurev.immunol.25.022106.141609
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2895922

R. Pries, S. Nitsch, and B. Wollenberg, Role of cytokines in head and neck squamous cell carcinoma, Expert Review of Anticancer Therapy, vol.6, issue.9, pp.1195-1203, 2006.
DOI : 10.1586/14737140.6.9.1195

A. Taylor, J. Verhagen, K. Blaser, M. Akdis, and C. A. , Mechanisms of immune suppression by interleukin-10 and transforming growth factor-beta: the role of T regulatory cells, Immunology, vol.156, issue.4, pp.433-442, 2006.
DOI : 10.1159/000080523

A. H. Enk, H. Jonuleit, J. Saloga, and J. Knop, Dendritic cells as mediators of tumor-induced tolerance in metastatic melanoma, International Journal of Cancer, vol.183, issue.3, pp.309-316, 1997.
DOI : 10.1002/(SICI)1097-0215(19971104)73:3<309::AID-IJC1>3.0.CO;2-3

F. O. Nestle, G. Burg, J. Fah, T. Wrone-smith, and B. J. Nickoloff, Human sunlight-induced basal-cell carcinomaassociated dendritic cells are deficient in T cell co stimulatory molecules and are impaired as antigen presenting cells, Am. J. Pathol, pp.150-641, 1997.

M. A. Stene, M. Babajanians, S. Bhuta, and A. J. Cochran, Quantitative Alterations in Cutaneous Langerhans Cells During the Evolution of Malignant Melanoma of the Skin, Journal of Investigative Dermatology, vol.91, issue.2, pp.91-125, 1988.
DOI : 10.1111/1523-1747.ep12464142

K. Toriyama, D. R. Wen, E. Paul, and A. J. Cochran, Variations in the Distribution, Frequency, and Phenotype of Langerhans Cells During the Evolution of Malignant Melanoma of the Skin, Journal of Investigative Dermatology, vol.100, issue.3, pp.269-273, 1993.
DOI : 10.1038/jid.1993.48

K. Wojas, J. Tabarkiewicz, M. Jankiewicz, and J. Rolinski, Dendritic cells in peripheral blood of patients with breast and lung cancer ? a pilot study, Folia Histochem. Cytobiol, pp.42-45, 2004.

S. , D. Bella, M. Gennaro, M. Vaccari, C. Ferraris et al., Altered maturation of peripheral blood dendritic cells in patients with breast cancer, Br. J. Cancer, vol.89, pp.1463-1472, 2003.

G. Laguens, S. Coronato, R. Laguens, E. Portiansky, and V. D. Girolamo, Human regional lymph nodes draining cancer exhibit a profound dendritic cell depletion as comparing to those from patients without malignancies, Immunology Letters, vol.84, issue.3, pp.159-162, 2002.
DOI : 10.1016/S0165-2478(02)00172-4

H. E. Kohrt, N. Nouri, K. Nowels, D. Johnson, S. Holmes et al., Profile of Immune Cells in Axillary Lymph Nodes Predicts Disease-Free Survival in Breast Cancer, PLoS Medicine, vol.16, issue.9, 2005.
DOI : 10.1371/journal.pmed.0020284.sg004

G. M. Halliday, A. D. Lucas, and R. S. Barnetson, Control of Langerhans' cell density by a skin tumour-derived cytokine, Immunology, vol.77, pp.13-18, 1992.

D. Bell, P. Chomarat, D. Broyles, G. Netto, G. M. Harb et al., In Breast Carcinoma Tissue, Immature Dendritic Cells Reside within the Tumor, whereas Mature Dendritic Cells Are Located in Peritumoral Areas, Journal of Experimental Medicine, vol.190, issue.10, pp.190-1417, 1999.
DOI : 10.1084/jem.190.10.1417

W. Zou, V. Machelon, A. Coulomb-l-'hermin, J. Borvak, F. Nome et al., Stromalderived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells, Nature Medicine, vol.7, issue.12, pp.1339-1346, 2001.
DOI : 10.1038/nm1201-1339

M. Ratta, F. Fagnoni, A. Curti, R. Vescovini, P. Sansoni et al., Dendritic cells are functionally defective in multiple myeloma: the role of interleukin-6, Blood, vol.100, issue.1, pp.230-237, 2002.
DOI : 10.1182/blood.V100.1.230

B. Almand, J. R. Resser, and B. Lindman, Clinical significance of defective dendritic cell differentiation in cancer, Clin. Cancer, vol.6, pp.1755-1766, 2000.

B. Almand, J. I. Clark, and E. Nikitina, Increased Production of Immature Myeloid Cells in Cancer Patients: A Mechanism of Immunosuppression in Cancer, The Journal of Immunology, vol.166, issue.1, pp.678-689, 2001.
DOI : 10.4049/jimmunol.166.1.678

A. J. Troy, P. J. Davidson, C. H. Atkinson, and D. N. Hart, CD1a dendritic cells predominate in transitional cell carcinoma of bladder and kidney but are minimally activated, J. Urol, pp.161-1962, 1999.

F. A. Harding, J. G. Mcarthur, J. A. Gross, D. H. Raulet, and J. P. Allison, CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones, Nature, vol.356, issue.6370, pp.607-609, 1992.
DOI : 10.1038/356607a0

K. Bennaceur, I. Popa, J. Portoukalian, O. Berthier-vergnes, and J. Peguet-navarro, Melanoma-derived gangliosides impair migratory and antigen-presenting function of human epidermal Langerhans cells and induce their apoptosis, International Immunology, vol.18, issue.6, pp.879-886, 2006.
DOI : 10.1093/intimm/dxl024
URL : https://hal.archives-ouvertes.fr/inserm-00077810

C. Menetrier-caux, G. Montmain, M. C. Dieu, C. Bain, M. C. Favrot et al., Inhibition of the differentiation of dendritic cells from CD34(+) progenitors by tumor cells: role of interleukin-6 and macrophage colony-stimulating factor, Blood, vol.92, pp.4778-4791, 1998.

G. V. Shurin, M. R. Shurin, S. Bykovskaia, J. Shogan, M. T. Lotze et al., Neuroblastoma-derived gangliosides inhibit dendritic cell generation and function, Cancer Res, pp.61-363, 2001.

I. M. Luigi-dolcettia, B. Mantellia, E. Peranzonia, P. Zanovelloa, and V. Bronte, Myeloid-derived suppressor cell role in tumor-related inflammation, Cancer Lett, 2008.

I. Dmitry, V. Gabrilovich, S. Bronte, M. P. Chen, A. Colombo et al., The terminology issue for myeloid-derived suppressor cells, Cancer Res, vol.67, 2008.

R. Yang, Z. Cai, Y. Zhang, W. H. Yutzy, K. F. Roby et al., CD80 in Immune Suppression by Mouse Ovarian Carcinoma-Associated Gr-1+CD11b+ Myeloid Cells, Cancer Research, vol.66, issue.13, pp.6807-6815, 2006.
DOI : 10.1158/0008-5472.CAN-05-3755

B. Huang, P. I. Pan, and Q. Li, Gr-1+CD115+ Immature Myeloid Suppressor Cells Mediate the Development of Tumor-Induced T Regulatory Cells and T-Cell Anergy in Tumor-Bearing Host, Cancer Research, vol.66, issue.2, pp.1123-1131, 2006.
DOI : 10.1158/0008-5472.CAN-05-1299

P. Sinha, V. K. Clements, and S. Ostrand-rosenberg, Inter- leukin-13-regulated M2 macrophages in combination with myeloid suppressor cells block immune surveillance against metastasis, Cancer Res, pp.65-11743, 2006.

R. Antonia, C. L. Burgess, A. L. Slingluff-jr, and . Mellor, Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase, Science, vol.297, pp.1867-1870, 2002.

A. L. Mellor and M. D. Munn, Ido expression by dendritic cells: tolerance and tryptophan catabolism, Nature Reviews Immunology, vol.467, issue.10, pp.762-774, 2004.
DOI : 10.1016/S0041-1345(00)02792-5

A. L. Mellor, B. Baban, P. Chandler, B. Marshall, K. Jhaver et al., Cutting Edge: Induced Indoleamine 2,3 Dioxygenase Expression in Dendritic Cell Subsets Suppresses T Cell Clonal Expansion, The Journal of Immunology, vol.171, issue.4, pp.171-1652, 2003.
DOI : 10.4049/jimmunol.171.4.1652

L. A. Harshyne, S. C. Watkins, A. Gambotto, and S. M. Barratt-boyes, Dendritic cells acquire antigens from live cells for cross-presentation to CTL, dendritic cells acquire antigens from live cells for cross-presentation to CTL, J. Immunol, pp.166-3717, 2001.

L. A. Harshyne, M. I. Zimmer, S. C. Watkins, and S. M. Barratt-boyes, A Role for Class A Scavenger Receptor in Dendritic Cell Nibbling from Live Cells, The Journal of Immunology, vol.170, issue.5, pp.2302-2309, 2003.
DOI : 10.4049/jimmunol.170.5.2302

F. Ghiringhelli, P. E. Puiq, S. Roux, A. Parcellier, E. Schmitt et al., Tumor cells convert immature myeloid dendritic cells into TGF-beta-secreting cells inducing CD4+CD25+ regulatory T cell proliferation, J. Exp. Med, pp.202-919, 2005.
DOI : 10.1084/jem.20050463
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2213166

A. Kukreja, A. Hutchinson, A. Mazumder, D. Vesole, R. Angitapalli et al., Bortezomib disrupts tumour?dendritic cell interactions in myeloma and lymphoma: therapeutic implications, British Journal of Haematology, vol.87, issue.1, pp.136-106, 2007.
DOI : 10.1056/NEJMoa030288

A. Kukreja, A. Hutchinson, K. Dhodapkar, A. Mazumder, D. Vesole et al., Enhancement of clonogenicity of human multiple myeloma by dendritic cells, The Journal of Experimental Medicine, vol.90, issue.8, pp.203-1859, 2006.
DOI : 10.1016/j.ccr.2005.03.037

N. J. Bahlis, A. M. King, D. Kolonias, L. M. Carlson, H. Y. Liu et al., CD28-mediated regulation of multiple myeloma cell proliferation and survival, Blood, vol.109, issue.11, pp.5002-5010, 2007.
DOI : 10.1182/blood-2006-03-012542

G. Coukos, F. Benencia, R. J. Buckanovich, and J. R. Conejo-garcia, The role of dendritic cell precursors in tumour vasculogenesis, British Journal of Cancer, vol.105, issue.7, pp.1182-1187, 2005.
DOI : 10.1073/pnas.0536882100

T. J. Curiel, P. Cheng, P. Mottram, X. Alvarez, L. Moons et al., Dendritic Cell Subsets Differentially Regulate Angiogenesis in Human Ovarian Cancer, Cancer Research, vol.64, issue.16, pp.5535-5538, 2004.
DOI : 10.1158/0008-5472.CAN-04-1272

H. Spits and L. Lanier, Natural Killer or Dendritic: What's in a Name?, Immunity, vol.26, issue.1, pp.11-16, 2007.
DOI : 10.1016/j.immuni.2007.01.004

F. Ghiringhelli, L. Apetoh, F. Housseau, G. Kroemer, and L. , Links between innate and cognate tumor immunity, Links between innate and cognate tumor immunity, pp.224-231, 2007.
DOI : 10.1016/j.coi.2007.02.003

J. Taieb, N. Chatput, C. Menard, L. Apetoh, E. Ullrich et al., A novel dendritic cell subset involved in tumor immunosurveillance, Nature Medicine, vol.167, issue.2, pp.214-219, 2006.
DOI : 10.1038/nm1356
URL : https://hal.archives-ouvertes.fr/hal-00080612

J. Huang, T. Tatsumi, E. Pizzoferrato, N. Vujanovic, and W. J. Storkus, Nitric oxide sensitizes tumor cells to dendritic cellmediated apoptosis, uptake, and cross-presentation, Cancer Res, pp.65-8461, 2005.
DOI : 10.1158/0008-5472.can-05-0654

P. Blanco, A. K. Palucka, M. Gill, V. Pascual, and J. Banchereau, Induction of Dendritic Cell Differentiation by IFN-alpha in Systemic Lupus Erythematosus, Science, vol.294, issue.5546, pp.1540-1543, 2001.
DOI : 10.1126/science.1064890

L. I. Gold, The role for transforming growth factor-beta (TGF-beta) in human cancer, Crit. Rev. Oncog, vol.10, pp.303-360, 1999.

K. S. Shim, K. H. Kim, W. S. Han, and E. B. Park, Elevated serum levels of transforming growth factor-?1 in patients with colorectal carcinoma, Cancer, vol.49, issue.3, pp.554-561, 1999.
DOI : 10.1002/(SICI)1097-0142(19990201)85:3<554::AID-CNCR6>3.0.CO;2-X

Y. Yamaguchi, H. Tsumura, M. Miwa, and K. Inaba, Contrasting Effects of TGF&hyphen;&beta;1 and TNF&hyphen;&alpha; on the Development of Dendritic Cells from Progenitors in Mouse Bone Marrow, Stem Cells, vol.359, issue.2, pp.15-144, 1997.
DOI : 10.1002/stem.150144

W. C. Lee, C. Zhong, S. Qian, Y. Wan, J. Gauldie et al., PHENOTYPE, FUNCTION, AND IN VIVO MIGRATION AND SURVIVAL OF ALLOGENEIC DENDRITIC CELL PROGENITORS GENETICALLY ENGINEERED TO EXPRESS TGF-??1,2, Transplantation, vol.66, issue.12, pp.1810-1817, 1998.
DOI : 10.1097/00007890-199812270-00040

K. Sato, H. Kawasaki, H. Nagayama, M. Enomoto, C. Morimoto et al., TGFbeta 1 reciprocally controls chemotaxis of human peripheral blood monocyte-derived dendritic cells via chemokine receptors, J. Immunol, pp.164-2285, 2000.

S. J. Park, T. Nakagawa, H. Kitamura, T. Atsumi, H. Kamon et al., IL-6 Regulates In Vivo Dendritic Cell Differentiation through STAT3 Activation, The Journal of Immunology, vol.173, issue.6, pp.173-3844, 2004.
DOI : 10.4049/jimmunol.173.6.3844

H. Saito, S. Tsujitani, M. Ikeguchi, M. Maeta, and N. Kaibara, Relationship between the expression of vascular endothelial growth factor and the density of dendritic cells in gastric adenocarcinoma tissue, British Journal of Cancer, vol.78, issue.12, pp.1573-1577, 1998.
DOI : 10.1038/bjc.1998.725

M. Toi, S. Kondo, H. Suzuki, Y. Yamamoto, K. Inada et al., Quantitative analysis of vascular endothelial growth factor in primary breast cancer, Cancer, vol.194, issue.6, pp.1101-1106, 1996.
DOI : 10.1002/(SICI)1097-0142(19960315)77:6<1101::AID-CNCR15>3.0.CO;2-5

D. Gabrilovich, T. Ishida, T. Oyama, S. Ran, V. Kravtsov et al., Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo, Blood, vol.92, pp.4150-4166, 1998.

P. Lissoni, F. Malugani, A. Bonfanti, R. Bucovec, S. Secondino et al., Abnormally enhanced blood concentrations of vascular endothelial growth factor (VEGF) in metastatic cancer patients and their relation to circulating dendritic cells, IL-12 and endothelin-1, J. Biol. Regul. Homeost. Agents, vol.15, pp.140-144, 2001.

D. I. Gabrilovich, H. L. Chen, K. R. Girgis, H. T. Cunningham, G. M. Meny et al., Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells, Nature Medicine, vol.94, issue.10, pp.1096-1103, 1996.
DOI : 10.1016/0925-5710(95)00412-2

J. E. Ohm, M. R. Shurin, C. Esche, M. T. Lotze, D. P. Carbone et al., Effect of vascular endothelial growth factor and FLT3 ligand on dendritic cell generation in vivo, J. Immunol, pp.163-3260, 1999.

S. Gately and W. W. Li, Multiple roles of COX-2 in tumor angiogenesis: a target for antiangiogenic therapy, Seminars in Oncology, vol.31, pp.31-33, 2004.
DOI : 10.1053/j.seminoncol.2004.03.040

M. Tsujii, S. Kawano, and R. N. Dubois, Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential, Proc. Natl. Acad. Sci. USA 94, pp.3336-3340, 1997.
DOI : 10.1073/pnas.94.7.3336

S. Sharma, M. Stolina, S. C. Yang, F. Baratelli, J. F. Lin et al., Tumor cyclooxygenase 2-dependent suppression of dendritic cell function, Clin. Cancer Res, vol.9, pp.961-968, 2003.

L. Yang, N. Yamagata, R. Yadav, S. Brandon, R. L. Courtney et al., Cancer-associated immunodeficiency and dendritic cell abnormalities mediated by the prostaglandin EP2 receptor, Journal of Clinical Investigation, vol.111, issue.5, pp.111-727, 2003.
DOI : 10.1172/JCI16492

C. C. Sombroek, A. G. Stam, A. J. Masterson, S. M. Lougheed, M. J. Schakel et al., Prostanoids Play a Major Role in the Primary Tumor-Induced Inhibition of Dendritic Cell Differentiation, The Journal of Immunology, vol.168, issue.9, pp.4333-4343, 2002.
DOI : 10.4049/jimmunol.168.9.4333

L. M. Ellis and I. J. Fidler, Angiogenesis and metastasis, European Journal of Cancer, vol.32, issue.14, pp.2451-2460, 1996.
DOI : 10.1016/S0959-8049(96)00389-9

M. R. Young, M. A. Wright, and M. E. Young, Antibodies to colony-stimulating factors block Lewis lung carcinoma cell stimulation of immune-suppressive bone marrow cells, Cancer Immunology Immunotherapy, vol.18, issue.3, pp.33-146, 1991.
DOI : 10.1007/BF01756134

P. Serafini, R. Carbley, K. A. Noonan, G. Tan, V. Bronte et al., High-Dose Granulocyte-Macrophage Colony-Stimulating Factor-Producing Vaccines Impair the Immune Response through the Recruitment of Myeloid Suppressor Cells, Cancer Research, vol.64, issue.17, pp.6337-6343, 2004.
DOI : 10.1158/0008-5472.CAN-04-0757

V. Bronte, D. B. Chappell, E. Apolloni, A. Cabrelle, M. Wang et al., Unopposed production of granulocyte-macrophage colony-stimulating factor by tumors inhibits CD8+ T cell responses by dysregulating antigen-presenting cell maturation, J. Immunol, pp.162-5728, 1999.

S. Kruger-krasagakes, K. Krasagakis, C. Garbe, E. Schmitt, C. Huls et al., Expression of interleukin 10 in human melanoma, British Journal of Cancer, vol.70, issue.6, pp.1182-1185, 1994.
DOI : 10.1038/bjc.1994.469

K. Steinbrink, M. Wolfl, H. Jonuleit, J. Knop, and A. H. Enk, Induction of tolerance by IL-10-treated dendritic cells, J. Immunol, vol.159, pp.4772-4780, 1997.

K. Steinbrink, H. Jonuleit, G. Muller, G. Schuler, J. Knop et al., Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8(+) T cells resulting in a failure to lyse tumor cells, Blood, vol.93, pp.1634-1642, 1999.

A. H. Enk, V. L. Angeloni, M. C. Udey, and S. I. Katz, Inhibition of Langerhans cell antigen-presenting function by IL-10. A role for IL-10 in induction of tolerance, J. Immunol, pp.151-2390, 1993.

S. Beissert, J. Hosoi, S. Grabbe, A. Asahina, and R. D. Granstein, IL-10 inhibits tumor antigen presentation by epidermal antigen-presenting cells, J. Immunol, vol.154, pp.1280-1286, 1995.

C. Caux, C. Massacrier, B. Vanbervliet, C. Barthelemy, Y. J. Liu et al., Interleukin 10 inhibits T cell alloreaction induced by human dendritic cells, International Immunology, vol.6, issue.8, pp.1177-1185, 1994.
DOI : 10.1093/intimm/6.8.1177

S. Hakomori, Structure, organization, and function of glycosphingolipids in membrane, Current Opinion in Hematology, vol.10, issue.1, pp.16-24, 2003.
DOI : 10.1097/00062752-200301000-00004

S. Birkle, G. Zeng, L. Gao, R. K. Yu, and J. Aubry, Role of tumor-associated gangliosides in cancer progression, Biochimie, vol.85, issue.3-4, pp.455-463, 2003.
DOI : 10.1016/S0300-9084(03)00006-3

J. Portoukalian, G. Zwingelstein, and J. F. Dore, Lipid Composition of Human Malignant Melanoma Tumors at Various Levels of Malignant Growth, European Journal of Biochemistry, vol.85, issue.1, pp.94-113, 1979.
DOI : 10.1016/0006-3002(57)90254-8

J. Peguet-navarro, M. Sportouch, I. Popa, O. Berthier, D. Schmitt et al., Gangliosides from Human Melanoma Tumors Impair Dendritic Cell Differentiation from Monocytes and Induce Their Apoptosis, The Journal of Immunology, vol.170, issue.7, pp.3488-3494, 2003.
DOI : 10.4049/jimmunol.170.7.3488
URL : https://hal.archives-ouvertes.fr/hal-00189862

R. H. Burdon, Superoxide and hydrogen peroxide in relation to mammalian cell proliferation, Free Radic, Biol. Med, vol.18, pp.775-794, 1995.

C. Chauveau, S. Rému, P. J. Royer, M. Hill, S. Tanguy-royer et al., Heme oxygenase-1 expression inhibits dendritic cell maturation and proinflammatory function but conserves IL-10 expression, Blood, vol.106, issue.5, pp.1694-1702, 2005.
DOI : 10.1182/blood-2005-02-0494

E. Kriehuber, W. Bauer, A. S. Charbonnier, D. Winter, S. Amatschek et al., Balance between NF-??B and JNK/AP-1 activity controls dendritic cell life and death, Blood, vol.106, issue.1, pp.175-183, 2005.
DOI : 10.1182/blood-2004-08-3072

M. E. Handley, M. Thakker, G. Pollara, B. M. Chain, and D. R. Katz, JNK activation limits dendritic cell maturation in response to reactive oxygen species by the induction of apoptosis, Free Radic, Biol. Med, pp.38-1637, 2005.

P. Monti, B. E. Leone, A. Zerbi, G. Balzano, S. Cainarca et al., Tumor-Derived MUC1 Mucins Interact with Differentiating Monocytes and Induce IL-10highIL-12low Regulatory Dendritic Cell, The Journal of Immunology, vol.172, issue.12, pp.172-7341, 2004.
DOI : 10.4049/jimmunol.172.12.7341

S. G. Rane and E. P. Reddy, Janus kinases: components of multiple signaling pathways, Oncogene, vol.19, issue.49, pp.5662-5679, 2000.
DOI : 10.1038/sj.onc.1203925

T. Nosaka and T. Kitamura, Janus kinases (JAKs) and signal transducers and activators of transcription (STATs) in hematopoietic cells, Int. J. Hematol, pp.71-309, 2000.

L. S. Steelman, S. C. Pohnert, J. G. Shelton, R. A. Franklin, F. E. Bertrand et al., JAK/STAT, Raf/MEK/ERK, PI3K/Akt and BCR-ABL in cell cycle progression and leukemogenesis, Leukemia, vol.18, issue.2, pp.189-218, 2004.
DOI : 10.1038/sj.leu.2403241

K. Imada and W. J. Leonard, The Jak-STAT pathway, Molecular Immunology, vol.37, issue.1-2, pp.1-11, 2000.
DOI : 10.1016/S0161-5890(00)00018-3

J. Bromberg and J. E. Darnell-jr, The role of STATs in transcriptional control and their impact on cellular function, Oncogene, vol.19, issue.21, pp.2468-2473, 2000.
DOI : 10.1038/sj.onc.1203476

I. M. Wang, H. Lin, S. J. Goldman, and M. Kobayashi, STAT-1 is activated by IL-4 and IL-13 in multiple cell types, Molecular Immunology, vol.41, issue.9, pp.41-873, 2004.
DOI : 10.1016/j.molimm.2004.04.027

Y. Nefedova, M. Huang, S. Kusmartsev, R. Bhattacharya, P. Cheng et al., Hyperactivation of STAT3 Is Involved in Abnormal Differentiation of Dendritic Cells in Cancer, The Journal of Immunology, vol.172, issue.1, pp.172-464, 2004.
DOI : 10.4049/jimmunol.172.1.464

R. F. Duarte and D. A. Frank, La v??a JAK-STAT de se??alizaci??n intracelular y su repercusi??n en oncog??nesis, inmunomodulaci??n y desarrollo, Medicina Cl??nica, vol.114, issue.6, pp.227-234, 2000.
DOI : 10.1016/S0025-7753(00)71252-8

T. Naka, M. Fujimoto, and T. Kishimoto, Negative regulation of cytokine signaling: STAT-induced STAT inhibitor, Trends in Biochemical Sciences, vol.24, issue.10, pp.394-398, 1999.
DOI : 10.1016/S0968-0004(99)01454-1

A. Baetz, M. Frey, K. Heeg, and A. H. Dalpke, Suppressor of cytokine signaling (SOCS) proteins indirectly regulate tolllike receptor signaling in innate immune cells, J. Biol. Chem, pp.279-54708, 2004.

S. H. Jackson, C. R. Yu, R. M. Mahdi, S. Ebong, and C. E. Egwuagu, Dendritic Cell Maturation Requires STAT1 and Is under Feedback Regulation by Suppressors of Cytokine Signaling, The Journal of Immunology, vol.172, issue.4, pp.172-2307, 2004.
DOI : 10.4049/jimmunol.172.4.2307

F. Cheng, H. W. Wang, A. Cuenca, M. Huang, T. Ghansah et al., A Critical Role for Stat3 Signaling in Immune Tolerance, Immunity, vol.19, issue.3, pp.425-436, 2003.
DOI : 10.1016/S1074-7613(03)00232-2